Home Pragmatic approach and variations in the management of pregnant women with type 1 diabetes mellitus on insulin pump: a case series
Article
Licensed
Unlicensed Requires Authentication

Pragmatic approach and variations in the management of pregnant women with type 1 diabetes mellitus on insulin pump: a case series

  • Varuna Nargunan ORCID logo EMAIL logo , Christopher A. Enakpene ORCID logo , Glen Bennion , Praveen D. Merugumala , Elisa Brown and Natalia Schlabritz-Loutsevitch
Published/Copyright: May 1, 2020

Abstract

Background

According to a 2017 Centers for Disease Control and Prevention (CDC) report, there were 23.1 million Americans living with diagnosed diabetes. Diabetes-related complications in pregnancy are spontaneous abortion, preterm delivery, preeclampsia, fetal malformations, altered fetal growth, polyhydramnios, and unexplained fetal demise. Continuous insulin delivery through insulin pump is used for effective management of type 1 diabetes (T1DM).

Case presentation

We present case reports of four patients who were on insulin pump for at least 1 year prior to pregnancy and continued throughout their pregnancy. Although these case reports demonstrated overall good pregnancy outcomes, it did not show how well their blood glucose was controlled during pregnancy.

Conclusion

Standard of care in diabetic management during pregnancy using insulin pump in the presented case reports supports the American Association of Clinical Endocrinologists recommendation that insulin pump should be used for women with preexisting T1DM during pregnancy.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  6. Ethical approval: The research related to human use has complied with all the relevant national regulations, institutional policies and has been conducted in accordance with the tenets of the Helsinki Declaration, and it has been approved by the authors’ Institutional Review Board or equivalent committee.

  7. Conflict of interest: I hereby declare on behalf of all the authors of this manuscript that in accordance with DE GRUYTER policy and my ethical obligation as a researcher, none of the authors listed in this manuscript have financial and/or business interests in a company that may be affected by the information reported in these case reports. Moreover, all authors listed here have contributed in various capacities in the conceptualization, patient care, literature search, writing and editing the manuscript up to this format.

Appendix

Continuous subcutaneous insulin pump uses only rapid acting insulin (lispro, aspart, glulisine), and all the four patients used aspart (Novo Nordisk, Plainsboro, NJ, USA).

Basal rate: This is the fixed rate of insulin dose that is programmed by the healthcare provider in the pump to deliver to patient. The delivery is continuous, but it can be programmed to alter delivery in each hour as needed. These rates can be set in fractions, and the total basal rate is the sum of a 24-hour settings. Alterations to the basal rates are based on the occurrences of hypoglycemic or hyperglycemic episodes at different times of the day.

Bolus setting: These are also preprogrammed by the healthcare provider in the pump, but the patient has to enter their blood glucose readings and the total carbohydrate intake for the pump to calculate the amount of insulin to be delivered. Once that information is fed to the pump based on the preprogramming, the pump will give the calculated amount of insulin and ask the patient to confirm before giving the bolus.

Estimation of basal insulin setting, an example using the patient in case # 1

From 12 midnight to 3 am, the pump is set at 0.7 unit/hour, giving 2.1 units during that period.

From 3 am to 6 am, it is set at 1.3 units/hour = 3.9 units.

From 6 am to 12 noon, 1.0 unit/hour = 6 units.

From 12 noon to 5 pm, it is again set at 1.0 unit/hour = 5 units.

From 5 pm to 9 pm, it is set at 1.1 units/hour = 4.4 units

From 9 pm to 12 midnight, 0.7 unit/hour = 2.1 units.

The total basal rate insulin for a 24-hour period is: 2.1 + 3.9 + 6.0 + 5.0 + 4.4 + 2.1 = 23.5 units

Moreover, the basal rate setting is also programmed to increase at an individual setting so that it can give extra insulin dose. If it is set to give extra 0.1 unit/hour, that will be 0.1 unit × 24 = 2.4 units. Then, the overall 24 hours basal insulin amount expected to be delivered for that individual will be increased from 23.5 units to 25.9 units, [23.5 + 2.4]. If it is set to give another extra 0.2 unit/hour across, it will be 0.2 unit × 24 hours = 4.8 units. Then, the total insulin expected for that individual in a 24-hour period will increase from 25.9 to 30.7 units [25.9 + 4.8].

References

[1] Center for Disease Control. National diabetes Factsheet: general information and national estimates on diabetes in the United States, 2017. Atlanta, GA: Centers for Disease Control and Prevention, Department of Health and Human Services, 2017; 2018.Search in Google Scholar

[2] Vargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstet Gynecol. 2010;3:92–100.Search in Google Scholar

[3] Uzun Cilingir IG. Pregnancy outcomes in women with strictly controlled type 1 diabetes mellitus. Indian J Endocrinol Metab. 2018;22:798–800.10.4103/ijem.IJEM_139_18Search in Google Scholar PubMed PubMed Central

[4] Wahabi HA, Esmaeil SA, Fayed A, Al-Shaikh G, Alzeidan RA. Pre-existing diabetes mellitus and adverse pregnancy outcomes. BMC Res Notes. 2012;5:496.10.1186/1756-0500-5-496Search in Google Scholar PubMed PubMed Central

[5] Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34:1683–8.10.2337/dc11-0244Search in Google Scholar PubMed PubMed Central

[6] Márquez-Valadez B, Valle-Bautista R, García-López G, Díaz NF, Molina-Hernández A. Maternal diabetes and fetal programming toward neurological diseases: beyond neural tube defects. Front Endocrinol. 2018;9:664.10.3389/fendo.2018.00664Search in Google Scholar PubMed PubMed Central

[7] Bernasko J. Insulin pump therapy for pregnancy: a primer. J Matern Fetal Neonatal Med. 2012;25:552–7.10.3109/14767058.2011.598586Search in Google Scholar PubMed

[8] Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies. Eur J Endocrinol. 2018;178:545–63.10.1530/EJE-17-0804Search in Google Scholar PubMed

[9] Kallas-Koeman MM, Kong JM, Klinke JA, Butalia S, Lodha AK, Lim KI, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014;57:681–9.10.1007/s00125-014-3163-6Search in Google Scholar PubMed

[10] Murphy HR. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters. Diabetologia. 2019;62:1123–8.10.1007/s00125-019-4904-3Search in Google Scholar PubMed PubMed Central

[11] Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JF, Sanchez JJ, et al. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care 2018;41:2471–9.10.2337/dc18-1437Search in Google Scholar PubMed

[12] Gutaj P, Zawiejska A, Brazert J, Wender-Ozegowska E. Association between preconceptional treatment with insulin pumps and improved metabolic status in early pregnancy in women with type 1 diabetes. Pol Arch Med Wewn. 2015;125:329–36.10.20452/pamw.2830Search in Google Scholar PubMed

[13] Law GR, Gilthorpe MS, Secher AL, Temple R, Bilous R, Mathiesen ER, et al. Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes. Diabetologia. 2017;60:618–24.10.1007/s00125-017-4205-7Search in Google Scholar PubMed PubMed Central

[14] Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53:446–51.10.1007/s00125-009-1633-zSearch in Google Scholar PubMed

[15] Weiss PA, Hofmann H. Intensified conventional insulin therapy for the pregnant diabetic patient. Obstet Gynecol. 1984;64:629–37.Search in Google Scholar

[16] Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, et al. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care. 2001;24:1130–6.10.2337/diacare.24.7.1130Search in Google Scholar PubMed

[17] Petrovski G, Dimitrovski C, Bogoev M, Milenkovic T, Ahmeti I, Bitovska I. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technol Ther. 2011;13:1109–13.10.1089/dia.2011.0081Search in Google Scholar PubMed

[18] Farrington C, Stewart Z, Hovorka R, Murphy H. Women’s experiences of day-and-night closed-loop insulin delivery during type 1 diabetes pregnancy. J Diabetes Sci Technol. 2018;12:1125–31.10.1177/1932296818800065Search in Google Scholar PubMed PubMed Central

Received: 2019-03-30
Accepted: 2020-01-31
Published Online: 2020-05-01

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Case Reports – Obstetrics
  2. Fetal pulmonary choristoma: report of first case and literature review
  3. Ultrasound prenatal diagnosis of a de novo 14q distal duplication associated with foetal anomalies: a case report
  4. Prenatal diagnosis of Kleefstra syndrome
  5. Cardiac implant and the risk of infective endocarditis in pregnancy
  6. Iatrogenic fetal goiter. Conservative management and spontaneous resolution
  7. Management in cases of large uterine myomas in pregnancy
  8. Significantly enlarged varix in the free-loop of the umbilical cord during the second trimester
  9. A case report of co-infection with rhinovirus and SARS-CoV-2 in pregnancy
  10. Monoamniotic twins pregnancy complicated by a fetal congenital heart defect – a challenge for perinatal decisions
  11. Favorable outcome after nine minutes of shoulder dystocia preceded by a tight nuchal cord
  12. Circumvallate placenta and abnormal cord insertion as risk factors for intrauterine growth restriction and preterm birth: a case report
  13. A rare case of intra-uterine blood transfusion for fetal anemia caused by a giant placental chorioangioma
  14. Septated fetal bladder in a case of 2q13 deletion
  15. A case of prenatal diagnosis of single umbilical artery due to thrombosis diagnosed by the ultrasound finding of “wink-sign”
  16. Ultrasound diagnosis of myelomeningocele: the role of 3D ultrasonography in determining surficial status of the pathological lesion
  17. Pragmatic approach and variations in the management of pregnant women with type 1 diabetes mellitus on insulin pump: a case series
  18. A great pre-eclampsia masquerader. Hemophagocytic lymphohistiocytosis (HLH) presenting in pregnancy
  19. Survival of both twins in a pregnancy complicated by pre-viable cord prolapse at 21 weeks of gestation
  20. A case report of a pregnant woman diagnosed with intrahepatic cholangiocarcinoma (ICC) complicated by opioid tolerance
  21. Prenatal and postnatal imaging of an intrapericardial teratoma
  22. Case report of a ruptured uterine sacculation in the 19th week of pregnancy
  23. Is thromboelastography reliable in postpartum coagulopathies? Two case reports and a literature review
  24. Prenatal diagnosis of megacystis-microcolon-intestinal hypoperistalsis syndrome
  25. Fetal head entrapment within the lower uterine segment
  26. Case Reports – Fetus
  27. A case of diprosopus: a rare form of twinning radiology-pathology correlation
  28. Case Reports – Newborn
  29. Transmission of SARS-CoV-2 to premature twins from an asymptomatic mother
  30. Spinal dysraphism, club feet, and dextrocardia with situs inversus totalis in a neonate: a rare association and review
  31. Giant congenital vascular malformation: diagnostic approach and clinical course
  32. Transient neonatal myasthenia gravis following maternal myasthenia gravis presenting in pregnancy after treatment with Alemtuzumab
  33. Congenital pulmonary lymphangiectasia in an extremely low birth weight: a case report
  34. Congenital kaposiform hemangioendothelioma: don’t let the appearances fool you
  35. Agnathia-otocephaly complex: a case report and a literature review on recurrence risk
  36. Perinatal severe hypophosphatasia: a case report
  37. Recurrent neonatal group B streptococcus cellulitis and adenitis syndrome with late-onset sepsis
  38. Neonatal hypertension caused by left-to-right shunt flow through a patent ductus arteriosus in a premature infant
  39. Maternal Babesia infection associated with neonatal extramedullary hematopoiesis and acute myeloid leukemia in late infancy
  40. Congenital high airway obstruction syndrome complicated with foregut malformation and high airway fistula to the alimentary tract – a case series with four distinct types
  41. Aplasia cutis congenita as a consequence of fetal reduction in a triplet pregnancy
  42. Anhydramnios, but prenatally normal kidneys: renal tubular dysgenesis – patient with mutations in the renin-angiotensin system gene AGTR1
  43. Symptomatic and lethal congenital primary cardiac rhabdomyoma
Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/crpm-2019-0023/html?lang=en
Scroll to top button